Federated Hermes
REGN icon

Federated Hermes’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$129M Buy
245,587
+204,045
+491% +$107M 0.24% 109
2025
Q1
$26.3M Buy
41,542
+5,579
+16% +$3.54M 0.06% 349
2024
Q4
$25.6M Buy
35,963
+30,304
+536% +$21.6M 0.06% 361
2024
Q3
$5.95M Buy
5,659
+1,875
+50% +$1.97M 0.01% 684
2024
Q2
$3.98M Sell
3,784
-6,391
-63% -$6.72M 0.01% 770
2024
Q1
$9.79M Buy
10,175
+6,961
+217% +$6.7M 0.02% 574
2023
Q4
$2.82M Buy
3,214
+418
+15% +$367K 0.01% 859
2023
Q3
$2.3M Buy
2,796
+160
+6% +$132K 0.01% 877
2023
Q2
$1.89M Buy
2,636
+335
+15% +$241K ﹤0.01% 972
2023
Q1
$1.89M Sell
2,301
-136
-6% -$112K ﹤0.01% 976
2022
Q4
$1.76M Sell
2,437
-2,605
-52% -$1.88M ﹤0.01% 953
2022
Q3
$3.47M Buy
5,042
+371
+8% +$256K 0.01% 753
2022
Q2
$2.76M Buy
4,671
+1,071
+30% +$633K 0.01% 848
2022
Q1
$2.51M Sell
3,600
-55
-2% -$38.4K 0.01% 975
2021
Q4
$2.31M Buy
3,655
+230
+7% +$145K ﹤0.01% 1005
2021
Q3
$2.07M Sell
3,425
-242
-7% -$146K ﹤0.01% 1035
2021
Q2
$2.05M Buy
3,667
+141
+4% +$78.7K ﹤0.01% 1090
2021
Q1
$1.67M Sell
3,526
-922
-21% -$436K ﹤0.01% 1173
2020
Q4
$2.15M Buy
4,448
+572
+15% +$276K ﹤0.01% 1037
2020
Q3
$2.17M Buy
3,876
+167
+5% +$93.5K 0.01% 955
2020
Q2
$2.31M Sell
3,709
-191,254
-98% -$119M 0.01% 945
2020
Q1
$95.2M Buy
194,963
+156,470
+406% +$76.4M 0.28% 75
2019
Q4
$14.5M Buy
38,493
+25,232
+190% +$9.47M 0.03% 510
2019
Q3
$3.68M Sell
13,261
-1,858
-12% -$515K 0.01% 852
2019
Q2
$4.73M Sell
15,119
-16,889
-53% -$5.29M 0.01% 799
2019
Q1
$13.1M Buy
32,008
+12,477
+64% +$5.12M 0.03% 465
2018
Q4
$7.29M Buy
19,531
+17,234
+750% +$6.44M 0.02% 619
2018
Q3
$928K Sell
2,297
-221
-9% -$89.3K ﹤0.01% 1371
2018
Q2
$868K Sell
2,518
-938
-27% -$323K ﹤0.01% 1327
2018
Q1
$1.19M Buy
3,456
+334
+11% +$115K ﹤0.01% 1166
2017
Q4
$1.17M Sell
3,122
-196
-6% -$73.7K ﹤0.01% 1161
2017
Q3
$1.48M Sell
3,318
-800
-19% -$358K ﹤0.01% 1053
2017
Q2
$2.02M Sell
4,118
-238
-5% -$117K 0.01% 910
2017
Q1
$1.69M Sell
4,356
-150,015
-97% -$58.1M ﹤0.01% 974
2016
Q4
$56.7M Buy
154,371
+151,187
+4,748% +$55.5M 0.17% 118
2016
Q3
$1.28M Buy
3,184
+79
+3% +$31.8K ﹤0.01% 1027
2016
Q2
$1.09M Sell
3,105
-35
-1% -$12.2K ﹤0.01% 1075
2016
Q1
$1.13M Sell
3,140
-2,408
-43% -$868K ﹤0.01% 1044
2015
Q4
$3.01M Sell
5,548
-604
-10% -$328K 0.01% 717
2015
Q3
$2.86M Sell
6,152
-3,069
-33% -$1.43M 0.01% 727
2015
Q2
$4.7M Buy
9,221
+1,365
+17% +$696K 0.01% 625
2015
Q1
$3.55M Sell
7,856
-4,854
-38% -$2.19M 0.01% 728
2014
Q4
$5.22M Sell
12,710
-108,563
-90% -$44.5M 0.02% 597
2014
Q3
$43.7M Sell
121,273
-134
-0.1% -$48.3K 0.14% 140
2014
Q2
$34.3M Buy
121,407
+19,235
+19% +$5.43M 0.11% 190
2014
Q1
$30.7M Buy
102,172
+10,960
+12% +$3.29M 0.1% 194
2013
Q4
$25.1M Buy
91,212
+17,170
+23% +$4.73M 0.09% 216
2013
Q3
$23.2M Buy
74,042
+11,140
+18% +$3.49M 0.09% 185
2013
Q2
$14.1M Buy
+62,902
New +$14.1M 0.06% 266